Vitrafy Life Sciences has established its scientific advisory board, with IVF pioneer Associate Professor John McBain appointed as the inaugural chair.
Fresh from closing an oversubscribed pre-IPO capital raise last month, cryopreservation company Vitrafy Life Sciences is gearing up for a float in the fourth quarter of this calendar year.
Vitrafy, a Ballarat-based company improving the preservation of biological matter, is going global, with a new partnership in the United States.
San Antonio-based BioBridge Global and Australia’s Vitrafy Life Sciences partner to develop new cryopreservation systems for the advancement of human blood services and advanced cellular therapies.
Former Bellamy’s Organic chairman Rob Woolley has popped up as a major shareholder and chair of a biomedical cryopreservation company that has raised $7.9 million ahead of an anticipated public float.
Copyright © 2023 Vitrafy Life Sciences Ltd | site by mulcahymarketing.com.au